The Ocean Genome Legacy Center and Seacoast Science Center join forces to unlock the secrets of marine mammal DNA and advance ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Q1 2025 Management View The company announced a strategic restructuring to focus on its LineaRx subsidiary, exiting the DNA Tagging and Security Products and Services segment. This move is expected to ...

MaizeCODE is a genomic project analyzing the genetic basis of maize domestication. Researchers identified key regulatory ...

STONY BROOK, NY - Applied DNA Sciences Inc . (NASDAQ:APDN), a company specializing in testing laboratories currently trading at $0.17 per share with a market capitalization of $8.89 million, reported ...

This week at AAAS, PNNL scientists and colleagues discuss phenomics, exposomics, and the factors that influence DNA ...

Why are lemons sour? Delve into the genetic explanations behind the tartness of lemons and their production of citric acid.

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

New CABI-led research using publicly-shared DNA barcodes and citizen science images have provided new evidence on the ...

STONY BROOK, N.Y. (AP) — STONY BROOK, N.Y. (AP) — Applied DNA Sciences Inc. (APDN) on Thursday reported a loss of $2.6 million in its fiscal first quarter. The Stony Brook, New York-based company said ...